[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate

C25H27N3O6 — CID 55524612

IUPAC[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate
SMILESCCC1(c2ccccc2)NC(=O)N(CC(=O)OC(C)C(=O)NC2CCOc3ccccc32)C1=O
InChIInChI=1S/C25H27N3O6/c1-3-25(17-9-5-4-6-10-17)23(31)28(24(32)27-25)15-21(29)34-16(2)22(30)26-19-13-14-33-20-12-8-7-11-18(19)20/h4-12,16,19H,3,13-15H2,1-2H3,(H,26,30)(H,27,32)
InChIKeyLGVKUTAJNUVUNS-UHFFFAOYSA-N
MW465.51 g/mol
LogP2.42
Rot. Bonds7

About [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate

[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate (PubChem CID 55524612) has the molecular formula C25H27N3O6 and a molecular weight of 465.51 g/mol. Its IUPAC name is [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate.

Molecular Properties

Compound Name[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate
PubChem CID55524612
Molecular FormulaC25H27N3O6
Molecular Weight465.51 g/mol
Exact Mass465.19
IUPAC Name[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate
SMILESCCC1(c2ccccc2)NC(=O)N(CC(=O)OC(C)C(=O)NC2CCOc3ccccc32)C1=O
InChIInChI=1S/C25H27N3O6/c1-3-25(17-9-5-4-6-10-17)23(31)28(24(32)27-25)15-21(29)34-16(2)22(30)26-19-13-14-33-20-12-8-7-11-18(19)20/h4-12,16,19H,3,13-15H2,1-2H3,(H,26,30)(H,27,32)
InChIKeyLGVKUTAJNUVUNS-UHFFFAOYSA-N
XLogP2.42
TPSA114.04 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500465.51
LogP ≤ 52.42
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate?
The IUPAC name of [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate (CID 55524612) is [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate.
What is the SMILES notation for [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate?
The canonical SMILES for [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate is CCC1(c2ccccc2)NC(=O)N(CC(=O)OC(C)C(=O)NC2CCOc3ccccc32)C1=O.
What is the InChIKey of [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate?
The InChIKey is LGVKUTAJNUVUNS-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27N3O6/c1-3-25(17-9-5-4-6-10-17)23(31)28(24(32)27-25)15-21(29)34-16(2)22(30)26-19-13-14-33-20-12-8-7-11-18(19)20/h4-12,16,19H,3,13-15H2,1-2H3,(H,26,30)(H,27,32).
What are the key properties of [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate?
[1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate has a molecular weight of 465.51 g/mol, XLogP of 2.42, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(3,4-dihydro-2H-chromen-4-ylamino)-1-oxopropan-2-yl] 2-(4-ethyl-2,5-dioxo-4-phenylimidazolidin-1-yl)acetate is sourced from PubChem (CID 55524612), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).